Regeneus Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 11

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 4

  • Investments
  • 3

Regeneus General Information

Description

Cambium Bio Ltd is a clinical-stage regenerative medicine company in Australia. It focuses on the development of biologics for ophthalmology and tissue repair applications. Its technology platform is based on human platelet lysate, which is being leveraged to create a pipeline of novel therapeutics, with a primary focus on ophthalmology. The company's product candidate Elate Ocular is being developed to address unmet medical needs in the treatment of dry eye disease. In addition, its stem cell platform, Progenza, is being applied to the development of therapies for knee osteoarthritis and other tissue repair indications.

Contact Information

Website
www.regeneus.com.au
Formerly Known As
Regeneus Limited
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 16 Goodhope Street
  • Paddington, New South Wales 2021
  • Australia
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Cambium Bio
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 16 Goodhope Street
  • Paddington, New South Wales 2021
  • Australia

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Regeneus Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Regeneus‘s full profile, request access.

Request a free trial

Regeneus Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Cambium Bio Ltd is a clinical-stage regenerative medicine company in Australia. It focuses on the development of biologi
Biotechnology
Paddington, Australia
11 As of 2024

New York, NY
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Regeneus Competitors (62)

One of Regeneus’s 62 competitors is Neurogene, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Neurogene Formerly VC-backed New York, NY
Capricor Therapeutics Formerly VC-backed San Diego, CA
Lisata Therapeutics Corporation Basking Ridge, NJ
Surrozen Formerly VC-backed South San Francisco, CA
Coya Therapeutics Formerly VC-backed Houston, TX
You’re viewing 5 of 62 competitors. Get the full list »

Regeneus Patents

  • 44

    Total Documents Applications and Grants

  • Total Patents Families

  • 10

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Regeneus Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018904529-A0 Cell selection method Inactive 28-Nov-2018
AU-2015905309-A0 Therapeutic methods using erythrocytes Inactive 22-Dec-2015
AU-2015904075-A0 Blood preparation and profiling Inactive 07-Oct-2015
JP-2022027928-A Cell expansion culture method and therapeutic composition Pending 08-Sep-2015
JP-2022186992-A Cell expansion culture method and therapeutic composition Pending 08-Sep-2015 A61K31/737
To view Regeneus’s complete patent history, request access »

Regeneus Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Regeneus Investments & Acquisitions (3)

Regeneus’s most recent deal was a Reverse Merger with Cambium Bio for . The deal was made on 04-Apr-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Cambium Bio 04-Apr-2024 Reverse Merger Drug Discovery
Regeneus Japan 19-Dec-2019 Merger/Acquisition Drug Discovery
Regeneus Japan 24-May-2017 Joint Venture Drug Discovery
To view Regeneus’s complete investments and acquisitions history, request access »

Regeneus FAQs

  • When was Regeneus founded?

    Regeneus was founded in 2007.

  • Where is Regeneus headquartered?

    Regeneus is headquartered in Paddington, Australia.

  • What is the size of Regeneus?

    Regeneus has 11 total employees.

  • What industry is Regeneus in?

    Regeneus’s primary industry is Biotechnology.

  • Is Regeneus a private or public company?

    Regeneus is a Private company.

  • What is Regeneus’s current revenue?

    The current revenue for Regeneus is .

  • How much funding has Regeneus raised over time?

    Regeneus has raised $14M.

  • Who are Regeneus’s competitors?

    Neurogene, Capricor Therapeutics, Lisata Therapeutics, Surrozen, and Coya Therapeutics are some of the 62 competitors of Regeneus.

  • When was Regeneus acquired?

    Regeneus was acquired on 04-Apr-2024.

  • Who acquired Regeneus?

    Regeneus was acquired by Cambium Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process